On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Aldose Reductase and Taurine

TopicLeading institutions, researchers & key papers

Aldose Reductase and Taurine is a topic indexed in ScholarIQ from OpenAlex.

What is known about Aldose Reductase and Taurine?

ScholarIQrecord summary

This cluster of papers explores the cellular response to osmotic stress, with a focus on the role of aldose reductase, taurine, and the aldo-keto reductase superfamily in conditions such as diabetes, inflammation, and oxidative stress. It also delves into the implications for mitochondrial function, neuroprotection, and cardiovascular health.

How many works does Aldose Reductase and Taurine have?

ScholarIQindexed works

Aldose Reductase and Taurine has 72 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Aldose Reductase and Taurine?

ScholarIQopenalex

The OpenAlex for Aldose Reductase and Taurine is on the source record.

What are the most-cited papers on Aldose Reductase and Taurine?

ScholarIQmost cited works
The Aldo-Keto Reductase Superfamily and its Role in Drug Metabolism and Detoxification
Oleg A. Barski, Srinivas M. Tipparaju, Aruni Bhatnagar
Drug Metabolism Reviews. 2008551 CitationsOPEN ACCESS
Role of Aldose Reductase and Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic Options
Satish K. Srivastava, Kota V. Ramana, Aruni Bhatnagar
Endocrine Reviews. 2005525 CitationsOPEN ACCESS
Taurine deficiency as a driver of aging
Parminder Singh, Kishore Gollapalli, Stefano Mangiola, Daniela Schranner, Mohd Aslam Yusuf, Manish Chamoli, Sting L. Shi, Bruno Lopes-Bastos, Tripti Nair, Annett Riermeier, Elena Vayndorf, Judy Wu, Aishwarya Nilakhe, Christina Q. Nguyen, Michael Muir, Michael G. Kiflezghi, Anna Foulger, Alex Junker, Jack Devine, Kunal Sharan, Shankar J. Chinta, Swati Rajput, Anand Rane, Philipp Baumert, Martin Schönfelder, Francescopaolo Iavarone, Giorgia Di Lorenzo, Swati Kumari, Alka Gupta, Rajesh Sarkar, Costerwell Khyriem, Amanpreet Singh Chawla, Ankur Sharma, Nazan Sarper, Naibedya Chattopadhyay, B.K. Biswal, Carmine Settembre, Perumal Nagarajan, Kimara L. Targoff, Martin Picard, Sarika Gupta, Vidya Velagapudi, Anthony T. Papenfuss, Alaattin Kaya, Miguel Godinho Ferreira, Brian K. Kennedy, Julie K. Andersen, Gordon J. Lithgow, Abdullah Mahmood Ali, Arnab Mukhopadhyay, Aarno Palotie, Gabi Kastenmüller, Matt Kaeberlein, Henning Wackerhage, Bhupinder Pal, Vijay K. Yadav
Science. 2023429 CitationsOPEN ACCESS
Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy
Nigishi Hotta, Yasuo Akanuma, Ryuzo Kawamori, Kempei Matsuoka, Yoshitomo Oka, Motoaki Shichiri, Takayoshi Toyota, Mitsuyoshi Nakashima, Isao Yoshimura, Nobuo Sakamoto, Yukio Shigeta, the ADCT Study Group
Diabetes Care. 2006366 CitationsOPEN ACCESS
Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family
Gregg Duester, Jaume Farrés, Michael R. Felder, Roger S. Holmes, Jan‐Olov Höög, Xavier Parés, Bryce V. Plapp, Shih‐Jiun Yin, Hans Jörnvall
Biochemical Pharmacology. 1999262 Citations

Where is Aldose Reductase and Taurine research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Aldose Reductase and Taurine is open access?

ScholarIQopen access share
40%OPEN ACCESS
Gold
13%
Green
7%
Hybrid
0%
Bronze
20%
Closed
60%

Related on ScholarIQ

470M+ articles · 14-day free trial